Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Allograft rejection is restrained by short-lived TIM-3+PD-1+Foxp3+ Tregs.

Gupta S, Thornley TB, Gao W, Larocca R, Turka LA, Kuchroo VK, Strom TB.

J Clin Invest. 2012 Jul;122(7):2395-404. doi: 10.1172/JCI45138. Epub 2012 Jun 11.

2.

The Tim-3/galectin-9 pathway involves in the homeostasis of hepatic Tregs in a mouse model of concanavalin A-induced hepatitis.

Ju Y, Shang X, Liu Z, Zhang J, Li Y, Shen Y, Liu Y, Liu C, Liu B, Xu L, Wang Y, Zhang B, Zou J.

Mol Immunol. 2014 Mar;58(1):85-91. doi: 10.1016/j.molimm.2013.11.001. Epub 2013 Dec 10.

PMID:
24333756
3.

Tim-3-Galectin-9 pathway involves the suppression induced by CD4+CD25+ regulatory T cells.

Wang F, Wan L, Zhang C, Zheng X, Li J, Chen ZK.

Immunobiology. 2009;214(5):342-9. doi: 10.1016/j.imbio.2008.10.007. Epub 2008 Dec 6.

PMID:
19362679
4.

Suppression of allograft rejection by Tim-1-Fc through cross-linking with a novel Tim-1 binding partner on T cells.

Xiao L, Fu ZR, Liu F, Zhang LD, Shi XM, Shen XY, Ni ZJ, Fu H, Li RD, Cao XT, Ding GS, Wang QX.

PLoS One. 2011;6(7):e21697. doi: 10.1371/journal.pone.0021697. Epub 2011 Jul 5.

5.

The amelioration of composite tissue allograft rejection by TIM-3-modified dendritic cell: Regulation of the balance of regulatory and effector T cells.

Wang Y, Zheng Z, Zhu X, Han J, Dong M, Tao K, Wang H, Wang Y, Hu D.

Immunol Lett. 2016 Jan;169:15-22. doi: 10.1016/j.imlet.2015.11.004. Epub 2015 Nov 10.

PMID:
26561949
6.

Tolerogenic dendritic cells suppress murine corneal allograft rejection by modulating CD28/CTLA-4 expression on regulatory T cells.

Yan F, Cai L, Hui Y, Chen S, Meng H, Huang Z.

Cell Biol Int. 2014 Jul;38(7):835-48. doi: 10.1002/cbin.10268. Epub 2014 Mar 14.

PMID:
24604878
7.

TIM-3: a novel regulatory molecule of alloimmune activation.

Boenisch O, D'Addio F, Watanabe T, Elyaman W, Magee CN, Yeung MY, Padera RF, Rodig SJ, Murayama T, Tanaka K, Yuan X, Ueno T, Jurisch A, Mfarrej B, Akiba H, Yagita H, Najafian N.

J Immunol. 2010 Nov 15;185(10):5806-19. doi: 10.4049/jimmunol.0903435. Epub 2010 Oct 18.

8.

Suppression of alloimmunity in mice by regulatory T cells converted with conditioned media.

Teng L, Liu L, Su Y, Yuan X, Li J, Fu Q, Chen S, Wang C.

J Surg Res. 2011 Dec;171(2):797-806. doi: 10.1016/j.jss.2010.03.044. Epub 2010 Apr 15.

PMID:
20538297
9.

Contrasting acute graft-versus-host disease effects of Tim-3/galectin-9 pathway blockade dependent upon the presence of donor regulatory T cells.

Veenstra RG, Taylor PA, Zhou Q, Panoskaltsis-Mortari A, Hirashima M, Flynn R, Liu D, Anderson AC, Strom TB, Kuchroo VK, Blazar BR.

Blood. 2012 Jul 19;120(3):682-90. doi: 10.1182/blood-2011-10-387977. Epub 2012 Jun 7.

10.

Tim-1 blockade with RMT1-10 increases T regulatory cells and prolongs the survival of high-risk corneal allografts in mice.

Tan X, Jie Y, Zhang Y, Qin Y, Xu Q, Pan Z.

Exp Eye Res. 2014 May;122:86-93. doi: 10.1016/j.exer.2014.02.019. Epub 2014 Mar 5.

PMID:
24613782
11.

Infiltrating Foxp3(+) regulatory T cells from spontaneously tolerant kidney allografts demonstrate donor-specific tolerance.

Hu M, Wang C, Zhang GY, Saito M, Wang YM, Fernandez MA, Wang Y, Wu H, Hawthorne WJ, Jones C, O'Connell PJ, Sparwasser T, Bishop GA, Sharland AF, Alexander SI.

Am J Transplant. 2013 Nov;13(11):2819-30. doi: 10.1111/ajt.12445. Epub 2013 Sep 18.

12.

Levels of Foxp3 in regulatory T cells reflect their functional status in transplantation.

Chauhan SK, Saban DR, Lee HK, Dana R.

J Immunol. 2009 Jan 1;182(1):148-53.

13.

Activation of Tim-3-Galectin-9 pathway improves survival of fully allogeneic skin grafts.

Wang F, He W, Yuan J, Wu K, Zhou H, Zhang W, Chen ZK.

Transpl Immunol. 2008 Apr;19(1):12-9. doi: 10.1016/j.trim.2008.01.008. Epub 2008 Feb 20.

PMID:
18346632
14.

Programmed Death-1 antibody blocks therapeutic effects of T-regulatory cells in cockroach antigen-induced allergic asthma.

McGee HS, Yagita H, Shao Z, Agrawal DK.

Am J Respir Cell Mol Biol. 2010 Oct;43(4):432-42. doi: 10.1165/rcmb.2009-0258OC. Epub 2009 Nov 9.

15.

Therapeutic polyclonal human CD8+ CD25+ Fox3+ TNFR2+ PD-L1+ regulatory cells induced ex-vivo.

Horwitz DA, Pan S, Ou JN, Wang J, Chen M, Gray JD, Zheng SG.

Clin Immunol. 2013 Dec;149(3):450-63. doi: 10.1016/j.clim.2013.08.007. Epub 2013 Aug 20.

16.
17.

Induction of transplantation tolerance by allogeneic donor-derived CD4(+)CD25(+)Foxp3(+) regulatory T cells.

Velásquez-Lopera MM, Eaton VL, Lerret NM, Correa LA, Decresce RP, García LF, Jaramillo A.

Transpl Immunol. 2008 May;19(2):127-35. doi: 10.1016/j.trim.2008.02.003. Epub 2008 Mar 20.

PMID:
18503888
18.

Comparative analysis of dendritic cells and anti-CD3/CD28 expanded regulatory T cells for application in transplantation.

Zeng M, Guinet E, Nouri-Shirazi M.

Transpl Immunol. 2009 Dec;22(1-2):82-92. doi: 10.1016/j.trim.2009.07.004. Epub 2009 Jul 25.

PMID:
19635560
19.

Increased CD4+Foxp3+ T cells in BAFF-transgenic mice suppress T cell effector responses.

Walters S, Webster KE, Sutherland A, Gardam S, Groom J, Liuwantara D, Mariño E, Thaxton J, Weinberg A, Mackay F, Brink R, Sprent J, Grey ST.

J Immunol. 2009 Jan 15;182(2):793-801.

20.

Induction of Foxp3-expressing regulatory T-cells by donor blood transfusion is required for tolerance to rat liver allografts.

Abe Y, Urakami H, Ostanin D, Zibari G, Hayashida T, Kitagawa Y, Grisham MB.

PLoS One. 2009 Nov 23;4(11):e7840. doi: 10.1371/journal.pone.0007840.

Supplemental Content

Support Center